About Teton

---

In 2011, I attended my first meeting of the Children's Tumor Foundation in Jackson Hole Wyoming, nestled among the Grand Teton Mountains.  I was amazed at the dedication and camaraderie of the physicians, scientists, and patients.  Unfortunately, I also observed a near-complete lack of interest by biotech and pharma.  I have since made it my mission to find a way to help these patients and families.  I encouraged my employers to work on NF for years, but eventually realized a focused company would help the most.  The name Teton Therapeutics commemorates the event where I became part of the NF community.

- Jonathan

Jonathan has been leading the development of new medicines for over 15 years.  He was most recently responsible for external R&D in the Rare Disease group at Pfizer.  Prior to that he led drug development teams at Alexion, Synageva, and BioMarin.  Jonathan began his career as a co-founder of Erimos Pharmaceuticals - a startup oncology business.  He has a PhD in Biology from The Johns Hopkins University and an MBA from The University of California Berkeley Haas School of Business.